Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormone Receptor-positive Breast Cancer
Interventions: DRUG: Cemiplimab|DRUG: Capecitabine
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Regeneron Pharmaceuticals